This program is directed toward providing basic and clinical research traiing in fundamentalaspectsof hematology for post-doctoral trainees with M.D. or Ph.D. degrees (currently 59) and basic research training in cell and molecular biology applicable to the broad goals of career training in medical research for pre- doctoral trainees with bachelors degrees who are pursuing Ph.D. and M.D./Ph.D. degrees (currently 40). The areas of research available to trainees reflect the broad range of interests of the training faculty (currently 21) and include: a variety of studies concerning the pathogenesis of thrombotic disorders; explorationof methods for gene therapy of coagulation and lysosomal enzyme defects; the pathways of phosphoinositide metabolism; hematopoesis and bone marrow failure, molecular basis for protein trafficking in mammalian cells; regulation of hemoglobin switching; role of platelets and angiogenesis in metastasisand molecular dissection of the interactions of human retroviruses. All trainees will conduct original investigations and participate in our seminar program. Predoctoral trainees will follow the curriculum of the graduate Division of Biology and Biomedical Sciences at Washington University. The major facilities of the research training program are comprised of 40,000 square feet of laboratoryspace in the Clinical Sciences Research Building and 20,000 square feet in the Southwest Tower which house the Divisions of Hematology and Molecular Oncology and our Howard Hughes Research unit. These facilities include all major items of equipment for modern biochemical, molecular biological and immunological research, including tissue-culture facilities for stem cell culture. We also have mouse facilities for embryo injection and transfer for the construction of transgenic and gene knockout mice. We are requesting continuing support for 8 postdoctoral trainees per year who will be trained from two to three years (i.e., 3 first year trainees; 3 second year trainees and 2 third year trainees),' and support for 7 predoctoral trainees who will be trained from three to four years.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007088-33
Application #
7341137
Study Section
Special Emphasis Panel (ZHL1-CSR-J (O1))
Program Officer
Chang, Henry
Project Start
1975-07-01
Project End
2011-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
33
Fiscal Year
2008
Total Cost
$641,666
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Celik, Hamza; Koh, Won Kyun; Kramer, Ashley C et al. (2018) JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells. Cancer Cell 34:741-756.e8
Trissal, Maria C; Wong, Terrence N; Yao, Juo-Chin et al. (2018) MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res 78:3510-3521
Ostrander, Elizabeth L; Koh, Won Kyun; Mallaney, Cates et al. (2018) The GNASR201C mutation associated with clonal hematopoiesis supports transplantable hematopoietic stem cell activity. Exp Hematol 57:14-20
Creamer, J Philip; Dege, Carissa; Ren, Qihao et al. (2017) Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4. Blood 129:2988-2992
Fisher, D A C; Malkova, O; Engle, E K et al. (2017) Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia. Leukemia 31:1962-1974
Shirai, Cara Lunn; White, Brian S; Tripathi, Manorama et al. (2017) Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome. Nat Commun 8:14060
Wagner, Julia A; Berrien-Elliott, Melissa M; Rosario, Maximillian et al. (2017) Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and Fc?RIIIa-Triggered Responses. Biol Blood Marrow Transplant 23:398-404
Cole, Christopher B; Russler-Germain, David A; Ketkar, Shamika et al. (2017) Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies. J Clin Invest 127:3657-3674
Johanns, Tanner M; Dunn, Gavin P (2017) Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma. Cancer J 23:125-130
Kramer, A C; Kothari, A; Wilson, W C et al. (2017) Dnmt3a regulates T-cell development and suppresses T-ALL transformation. Leukemia 31:2479-2490

Showing the most recent 10 out of 190 publications